Copyright Reports & Markets. All rights reserved.

Global RNAi Technologies Market Professional Survey Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on RNAi Technologies Industry
  • 1.7 COVID-19 Impact: RNAi Technologies Market Trends

    • 2 Global RNAi Technologies Quarterly Market Size Analysis

    • 2.1 RNAi Technologies Business Impact Assessment - COVID-19
      • 2.1.1 Global RNAi Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global RNAi Technologies Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global RNAi Technologies Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, RNAi Technologies Headquarters and Area Served
    • 3.3 Date of Key Players Enter into RNAi Technologies Market
    • 3.4 Key Players RNAi Technologies Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on RNAi Technologies Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Oncology
      • 1.4.2 Ocular disorders
      • 1.4.3 Respiratory disorders
      • 1.4.4 Liver diseases
      • 1.4.5 Other
    • 4.2 By Type, Global RNAi Technologies Market Size, 2019-2021

    5 Impact of Covid-19 on RNAi Technologies Segments, By Application

    • 5.1 Overview
      • 5.5.1 Research
      • 5.5.2 Therapeutics
    • 5.2 By Application, Global RNAi Technologies Market Size, 2019-2021
      • 5.2.1 By Application, Global RNAi Technologies Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Alnylam Pharmaceuticals
      • 7.1.1 Alnylam Pharmaceuticals Business Overview
      • 7.1.2 Alnylam Pharmaceuticals RNAi Technologies Quarterly Revenue, 2020
      • 7.1.3 Alnylam Pharmaceuticals RNAi Technologies Product Introduction
      • 7.1.4 Alnylam Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.2 Benitec Biopharma Ltd
      • 7.2.1 Benitec Biopharma Ltd Business Overview
      • 7.2.2 Benitec Biopharma Ltd RNAi Technologies Quarterly Revenue, 2020
      • 7.2.3 Benitec Biopharma Ltd RNAi Technologies Product Introduction
      • 7.2.4 Benitec Biopharma Ltd Response to COVID-19 and Related Developments
    • 7.3 Filmtec Corporation
      • 7.3.1 Filmtec Corporation Business Overview
      • 7.3.2 Filmtec Corporation RNAi Technologies Quarterly Revenue, 2020
      • 7.3.3 Filmtec Corporation RNAi Technologies Product Introduction
      • 7.3.4 Filmtec Corporation Response to COVID-19 and Related Developments
    • 7.4 Ionis Pharmaceuticals
      • 7.4.1 Ionis Pharmaceuticals Business Overview
      • 7.4.2 Ionis Pharmaceuticals RNAi Technologies Quarterly Revenue, 2020
      • 7.4.3 Ionis Pharmaceuticals RNAi Technologies Product Introduction
      • 7.4.4 Ionis Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.5 Quark Pharmaceuticals Inc.
      • 7.5.1 Quark Pharmaceuticals Inc. Business Overview
      • 7.5.2 Quark Pharmaceuticals Inc. RNAi Technologies Quarterly Revenue, 2020
      • 7.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Product Introduction
      • 7.5.4 Quark Pharmaceuticals Inc. Response to COVID-19 and Related Developments
    • 7.6 RXI Pharmaceuticals
      • 7.6.1 RXI Pharmaceuticals Business Overview
      • 7.6.2 RXI Pharmaceuticals RNAi Technologies Quarterly Revenue, 2020
      • 7.6.3 RXI Pharmaceuticals RNAi Technologies Product Introduction
      • 7.6.4 RXI Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.7 Qiagen
      • 7.7.1 Qiagen Business Overview
      • 7.7.2 Qiagen RNAi Technologies Quarterly Revenue, 2020
      • 7.7.3 Qiagen RNAi Technologies Product Introduction
      • 7.7.4 Qiagen Response to COVID-19 and Related Developments
    • 7.8 Invitrogen
      • 7.8.1 Invitrogen Business Overview
      • 7.8.2 Invitrogen RNAi Technologies Quarterly Revenue, 2020
      • 7.8.3 Invitrogen RNAi Technologies Product Introduction
      • 7.8.4 Invitrogen Response to COVID-19 and Related Developments
    • 7.9 Ambion
      • 7.9.1 Ambion Business Overview
      • 7.9.2 Ambion RNAi Technologies Quarterly Revenue, 2020
      • 7.9.3 Ambion RNAi Technologies Product Introduction
      • 7.9.4 Ambion Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of RNAi Technologies, including the following market information:
      Global RNAi Technologies Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global RNAi Technologies Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global RNAi Technologies Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global RNAi Technologies Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen, Ambion, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Oncology
      Ocular disorders
      Respiratory disorders
      Liver diseases
      Other

      Based on the Application:
      Research
      Therapeutics

      Buy now